DMAC logo

DiaMedica Therapeutics (DMAC)

Profile

Full Name

DiaMedica Therapeutics Inc.

Ticker Symbol

DMAC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 3, 2012

Indexes

Not included

Website

http://www.diamedica.com

Employees

27

Key Details

Price

$3.51(-0.85%)

Market cap

$150.42M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.60(0.00% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.51
DMAC price is $3.51

30-Day Relative Volume

0.70
DMAC 30-day relative volume is 0.70

Price Performance

Price Most recent change

-0.85%
DMAC price was down -0.85% on Apr 15, 2025

Price YTD change

-35.36%
DMAC price is down -35.36% since January 1st

Price 1-year change

+46.86%
DMAC price is up +46.86% year-on-year

Price 3-year change

+51.29%
DMAC price is up +51.29% over the past 3 years

Price Range

Price All-time high

$44.94
DMAC price is currently -92.19% below its historical high of $44.94

Price 3-year low

$1.12
DMAC price is currently +213.39% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$150.42M
DMAC market capitalization is $150.42 million

Market cap 3-year change

+145.2%
DMAC market capitalization is up +145.2% over the past 3 years

Market cap All-time high

$288.60M
DMAC market capitalization is currently -47.88% below its historical high of $288.60 million

Market cap sector rank

53.29%
DMAC market capitalization is higher than 53.29% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+12.89%
DMAC shares outstanding is up +12.89% year-on-year

Shares Outstanding 3-Year Change

+62.07%
DMAC shares outstanding is up +62.07% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.97
DMAC beta is 0.97

200-day SMA

$4.62
DMAC price is currently -23.99% below its 200-day simple moving average

50-day SMA

$5.26
DMAC price is currently -33.29% below its 50-day simple moving average

RSI

31.47
DMAC 14-day relative strength index is 31.47

Volume

0.70
DMAC 30-day relative volume is 0.70

ATR

$0.34
DMAC average true range is $0.34

10-day Historical Volatility

80.80%
DMAC 10-day historical volatility is 80.80%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
DMAC annual revenue value is unknown

Revenue Analysts estimate

-
DMAC annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
DMAC annual revenue 1-year change is unknown

Revenue Sector rank

-
DMAC annual revenue is unknown

EPS

EPS

-$0.60
DMAC annual earnings per share is -$0.60

EPS Analysts estimate

-$0.79
DMAC annual earnings per share is currently -23.81% lower than the consensus analysts' forecast

EPS 1-year change

0%
DMAC {parameterFullLabel} has remained unchanged year-on-year

EPS Sector rank

65.53%
DMAC annual earnings per share is higher than 65.53% of companies in Healthcare sector

Profit

Gross profit

-
DMAC annual gross profit value is unknown

Gross margin

-
DMAC annual gross profit margin value is unknown

Operating profit

-$26.68M
DMAC annual operating income is -$26.68 million

Operating margin

-
DMAC annual operating profit margin value is unknown

Net income

-$24.44M
DMAC annual net profit is -$24.44 million

Net margin

-
DMAC annual net profit margin value is unknown

Expenses

Total expenses

$26.68M
DMAC annual total expenses is $26.68 million

Operating expenses

$26.68M
DMAC annual total operating expenses is $26.68 million

Cost of goods sold

-
DMAC annual cost of goods sold value is unknown

Selling, general & administrative expenses

$7.62M
DMAC annual SGA is $7.62 million

Depreciation and amortization

$39.00K
DMAC annual depreciation & amortization is $39.00 thousand

Interest expense

-
DMAC annual interest expense value is unknown

Income tax

$30.00K
DMAC annual income tax is $30.00 thousand

EBIT & EBITDA

EBIT

-$26.68M
DMAC annual earnings before interest & taxes is -$26.68 million

EBITDA

-$26.64M
DMAC annual EBITDA is -$26.64 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$46.34M
DMAC annual total assets is $46.34 million

Non current assets

$1.74M
DMAC annual long term assets is $1.74 million

Current assets

$44.61M
DMAC annual total current assets is $44.61 million

Cash and cash equivalents

$3.02M
DMAC annual cash & cash equivalents is $3.02 million

Accounts receivable

$1000.00
DMAC annual accounts receivable is $1000.00

Inventory

-
DMAC annual inventory value is unknown

Liabilities

Total liabilities

$5.63M
DMAC annual total liabilities is $5.63 million

Long term liabilities

$237.00K
DMAC annual total long term liabilities is $237.00 thousand

Current liabilities

$5.39M
DMAC annual total current liabilities is $5.39 million

Accounts payable

$940.00K
DMAC annual accounts payable is $940.00 thousand

Debt

Total debt

$340.00K
DMAC annual total debt is $340.00 thousand

Total debt 1-year change

-15%
DMAC annual total debt is down -15% year-on-year

Long term debt

$237.00K
DMAC annual long term debt is $237.00 thousand

Short term debt

$103.00K
DMAC annual short term debt is $103.00 thousand

Equity & Capital

Shareholders equity

$40.72M
DMAC annual stockholders equity is $40.72 million

Book value

$40.72M
DMAC annual book value is $40.72 million

Retained earnings

-$140.00M
DMAC annual retained earnings is -$140.00 million

Working capital

$39.22M
DMAC annual working capital is $39.22 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$22.08M
DMAC annual cash flow from operations is -$22.08 million

Cash from operations 1-year change

-17.88%
DMAC annual cash flow from operations is down -17.88% year-on-year

Cash from investing

$8.56M
DMAC annual cash flow from investing activities is $8.56 million

Cash from investing 1-year change

+146.8%
DMAC annual cash flow from investing activities is up +146.8% year-on-year

Cash from financing

$11.99M
DMAC annual cash flow from financing activities is $11.99 million

Cash from financing 1-year change

-67.44%
DMAC annual cash flow from financing activities is down -67.44% year-on-year

CAPEX

CAPEX

-
DMAC annual capital expenditures value is unknown

CAPEX 1-year change

-
DMAC annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$22.10M
DMAC annual free cash flow is -$22.10 million

Free cash flow 1-year change

-17.86%
DMAC annual free cash flow is down -17.86% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
DMAC annual gross profit margin value is unknown

Operating margin

-
DMAC annual operating profit margin value is unknown

Net margin

-
DMAC annual net profit margin value is unknown

ROA & ROE

ROA

-52.74%
DMAC annual return on assets is -52.74%

ROE

-60.03%
DMAC annual return on equity is -60.03%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DMAC price to earnings ratio value is unknown

PE ratio Sector rank

-
DMAC price to earnings ratio is unknown

PB Ratio

PB ratio

3.69
DMAC price to book ratio is 3.69

PB ratio Sector rank

77.28%
DMAC price to book ratio is higher than 77.28% of companies in Healthcare sector

PS Ratio

PS ratio

-
DMAC price to sales ratio value is unknown

PS ratio Sector rank

-
DMAC price to sales ratio is unknown

Enterprise value

Enterprise value

$147.74M
DMAC enterprise value is $147.74 million

Enterprise value Sector rank

54.21%
DMAC enterprise value is higher than 54.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.55
DMAC EV/EBITDA is -5.55

EV/EBITDA Sector rank

17.57%
DMAC EV/EBITDA is higher than 17.57% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.28
DMAC annual current ratio is 8.28

Quick ratio

-
DMAC annual quick ratio value is unknown

Leverage

Debt to equity

0.01
DMAC annual debt to equity ratio is 0.01

Interest coverage ratio

-
DMAC annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
DMAC piotroski f-score value is unknown

Altman Z-Score

-
DMAC altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 19, 25 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Oct 10, 24 HC Wainwright & Co.
Buy
Oct 7, 24 HC Wainwright & Co.
Buy
Aug 16, 24 Oppenheimer
Outperform
Mar 21, 24 Oppenheimer
Outperform
Mar 21, 24 Craig-Hallum
Buy
Jun 22, 23 Oppenheimer
Outperform
Jul 7, 22 Oppenheimer
Perform
Jul 7, 22 Lake Street
Buy

Institutional Ownership

Similar stocks

ACIU logo
AC Immune SA (ACIU)
STXS logo
Stereotaxis (STXS)
TNGX logo
Tango Therapeutics (TNGX)
TARA logo
Protara Therapeutics (TARA)
PBYI logo
Puma Biotechnology (PBYI)
OPRX logo
OptimizeRx (OPRX)
MYO logo
Myomo (MYO)
ARAY logo
Accuray Incorporated (ARAY)
CLLS logo
Cellectis SA (CLLS)
  • What is the ticker symbol for DiaMedica Therapeutics?
  • Does DiaMedica Therapeutics pay dividends?
  • What sector is DiaMedica Therapeutics in?
  • What industry is DiaMedica Therapeutics in?
  • What country is DiaMedica Therapeutics based in?
  • When did DiaMedica Therapeutics go public?
  • Is DiaMedica Therapeutics in the S&P 500?
  • Is DiaMedica Therapeutics in the NASDAQ 100?
  • Is DiaMedica Therapeutics in the Dow Jones?
  • When was DiaMedica Therapeutics's last earnings report?
  • When does DiaMedica Therapeutics report earnings?
  • Should I buy DiaMedica Therapeutics stock now?

What is the ticker symbol for DiaMedica Therapeutics?

The ticker symbol for DiaMedica Therapeutics is NASDAQ:DMAC

Does DiaMedica Therapeutics pay dividends?

No, DiaMedica Therapeutics does not pay dividends

What sector is DiaMedica Therapeutics in?

DiaMedica Therapeutics is in the Healthcare sector

What industry is DiaMedica Therapeutics in?

DiaMedica Therapeutics is in the Biotechnology industry

What country is DiaMedica Therapeutics based in?

DiaMedica Therapeutics is headquartered in United States

When did DiaMedica Therapeutics go public?

DiaMedica Therapeutics's initial public offering (IPO) was on August 3, 2012

Is DiaMedica Therapeutics in the S&P 500?

No, DiaMedica Therapeutics is not included in the S&P 500 index

Is DiaMedica Therapeutics in the NASDAQ 100?

No, DiaMedica Therapeutics is not included in the NASDAQ 100 index

Is DiaMedica Therapeutics in the Dow Jones?

No, DiaMedica Therapeutics is not included in the Dow Jones index

When was DiaMedica Therapeutics's last earnings report?

DiaMedica Therapeutics's most recent earnings report was on Mar 18, 2025

When does DiaMedica Therapeutics report earnings?

The next expected earnings date for DiaMedica Therapeutics is May 9, 2025

Should I buy DiaMedica Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page